{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:47:10Z","timestamp":1758818830737,"version":"3.44.0"},"reference-count":8,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2015,8,19]]},"abstract":"<jats:p>Tyrosine kinase inhibitors, represented by sunitinib, sorafenib, axitinib and pazopanib, are emerging molecules harbouring antitumoural efficacy in multiple neoplasia. We report the case of a 51-year-old woman with right thoracic sarcoma who developed fatal heart failure on pazopanib. The patient had no cardiovascular risk factor, except previous exposure to anthracycline, and her cardiac function was normally controlled before initiating the pazopanib. Despite a rapid tumour response, fatigue rapidly appeared, requiring treatment interruption 2\u2005weeks after pazopanib introduction. After clinical improvement, the pazopanib was reintroduced at reduced dose; however, a few days later, our patient was admitted for worsening dyspnoea and fatigue. Pulmonary embolism was excluded as was pleuropericardial effusion. Brain natriuretic peptide was the only laboratory abnormality, and echocardiography revealed acute and severe heart failure. The patient died despite pazopanib arrest and inotropic support.<\/jats:p>","DOI":"10.1136\/bcr-2015-211522","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T04:26:29Z","timestamp":1441167989000},"page":"bcr2015211522","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Rapid and fatal acute heart failure induced by pazopanib"],"prefix":"10.1136","volume":"2015","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-0630","authenticated-orcid":false,"given":"C\u00e9dric","family":"van Marcke","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ledoux","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Petit","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Seront","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9764"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60651-5"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.3","first-page":"216","article-title":"Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"428","author":"Ghatalia","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.6331"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.5","doi-asserted-by":"crossref","first-page":"I290","DOI":"10.1161\/CIRCULATIONAHA.105.001289","article-title":"Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart","volume":"114","author":"Friehs","year":"2006","journal-title":"Circulation"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.6","doi-asserted-by":"publisher","DOI":"10.1161\/hc0502.103672"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-8062.2008.00090.x"},{"key":"2025082703121873000_2015.sep02_1.bcr2015211522.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9546-8"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2015-211522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:12:31Z","timestamp":1756289551000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2015-211522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":8,"alternative-id":["10.1136\/bcr-2015-211522"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2015-211522","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}